Guillain-Barré syndrome

From IDWiki

Background

Types

  • Guillain-Barré syndrome
    • Acute inflammatory demyelinating polyneuropathy (AIDP)
    • Acute motor axonal neuropathy
      • Acute motor-sensory axonal neuropathy
      • Acute motor-conduction-block neuropathy
      • Pharyngeal-cervical-branchial weakness
  • Miller Fisher syndrome
    • Incomplete MFS
      • Acute motor-ophthalmoparesis, without ataxia
      • Acute ataxic neyropathy, without ophthalmoparesis
    • Bickerstaff's brainstem encephalitis

Etiology

Pathophysiology

  • Immune crossreactivity causes autoimmune destruction of either the myelin sheath (AIDP) or the axon itself
  • Most common ADAM antibodies are anti-GM1 or anti-GD1a IgG, which recognize gangliosides
  • Most common MFS antibody is anti-GQ1b IgG (in 90%)

Epidemiology

  • About 1 case per 100,000 people per year in Western countries

Clinical Manifestations

  • Ascending paralysis ± sensory involvement
  • Usually occurs 1 to 2 weeks after an immune-stimulating even such as illness or vaccination
    • Preceding illness usually a gastrointestinal or respiratory infection
    • Campylobacter jejuni is the most common causative organism identified
    • Rare following influenza vaccination; most notable was the 1976 H1N1 vaccine, with about 1 in 100,000 vaccine recipients developing GBS

Differential Diagnosis

Further Reading